Cleveland Clinic's Dr. Matt Kalaycio Appointed Chair of Board of Directors for National Comprehensive Cancer Network

Dr. Christopher Lieu of the University of Colorado elected as incoming Vice-Chair for the alliance of leading cancer centers.

PLYMOUTH MEETING, Pa., April 8, 2024 — The National Comprehensive Cancer Network® (NCCN®)—a nonprofit devoted to patient care, research, and education—is announcing the election of Matt Kalaycio, MD, FACP, as Chair of the Board of Directors, with Christopher H. Lieu, MD, elected as Vice-Chair, succeeding Dr. Kalaycio in the position he has held since 2022.

NCCN elects Matt Kalaycio, MD, FACP, Vice-Chair of Cleveland Clinic Cancer Institute as Chair of the Board of Directors; Christopher H. Lieu, MD, Associate Director for Clinical Research for the University of Colorado Cancer Center, as Vice-Chair.